Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction - a post-hoc analysis of the EMMY trial.

Cardiovasc Diabetol · 2023 · PMC10324245 · PMID 37407956

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In this subgroup-analysis of the EMMY trial, we found highly significant correlations of hsCRP and IL-6 with troponin T in multivariable linear mixed analysis, suggesting an increased inflammation in larger AMI.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.